Compile Data Set for Download or QSAR
Report error Found 364 Enz. Inhib. hit(s) with all data for entry = 11789
TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648229BDBM648229(US11884671, Example 6)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50599238BDBM50599238(CHEMBL5181303 | US11884671, Example 29)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648243BDBM648243(US11884671, Example 20)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648233BDBM648233(US11884671, Example 13 | US11884671, Example 10)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648224BDBM648224(US11884671, Example 1)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648238BDBM648238(US11884671, Example 15)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648244BDBM648244(US11884671, Example 21)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648235BDBM648235(US11884671, Example 12)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648226BDBM648226(US11884671, Example 3)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648258BDBM648258(US11884671, Example 35)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648257BDBM648257(US11884671, Example 34)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648239BDBM648239(US11884671, Example 16)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648230BDBM648230(US11884671, Example 7)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648250BDBM648250(US11884671, Example 27)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648240BDBM648240(US11884671, Example 17)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648231BDBM648231(US11884671, Example 8)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648237BDBM648237(US11884671, Example 14)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648251BDBM648251(US11884671, Example 28)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648274BDBM648274(US11884671, Example 51)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648232BDBM648232(US11884671, Example 9)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50599239BDBM50599239(CHEMBL5184141 | US11884671, Example 32)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50599240BDBM50599240(CHEMBL5194436 | US11884671, Example 31)
Affinity DataIC50: 0.126nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50599237BDBM50599237(CHEMBL5180090 | US11884671, Example 30)
Affinity DataIC50: 0.126nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648245BDBM648245(US11884671, Example 22)
Affinity DataIC50: 0.158nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648234BDBM648234(US11884671, Example 11)
Affinity DataIC50: 0.158nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648249BDBM648249(US11884671, Example 26)
Affinity DataIC50: 0.158nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648242BDBM648242(US11884671, Example 19)
Affinity DataIC50: 0.158nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648225BDBM648225(US11884671, Example 2)
Affinity DataIC50: 0.158nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648233BDBM648233(US11884671, Example 13 | US11884671, Example 10)
Affinity DataIC50: 0.200nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648259BDBM648259(US11884671, Example 36)
Affinity DataIC50: 0.200nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648248BDBM648248(US11884671, Example 25)
Affinity DataIC50: 0.200nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648241BDBM648241(US11884671, Example 18)
Affinity DataIC50: 0.251nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648263BDBM648263(US11884671, Example 40)
Affinity DataIC50: 0.316nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648246BDBM648246(US11884671, Example 23)
Affinity DataIC50: 0.398nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50599234BDBM50599234(CHEMBL5170489 | US11884671, Example 52)
Affinity DataIC50: 0.501nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648256BDBM648256(US11884671, Example 33)
Affinity DataIC50: 0.501nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50599242BDBM50599242(CHEMBL5196848 | US11884671, Example 45)
Affinity DataIC50: 0.631nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50599243BDBM50599243(CHEMBL5192430 | US11884671, Example 37)
Affinity DataIC50: 0.631nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648247BDBM648247(US11884671, Example 24)
Affinity DataIC50: 0.794nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648228BDBM648228(US11884671, Example 5)
Affinity DataIC50: 0.794nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648227BDBM648227(US11884671, Example 4)
Affinity DataIC50: 1nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648270BDBM648270(US11884671, Example 47)
Affinity DataIC50: 1nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648271BDBM648271(US11884671, Example 48)
Affinity DataIC50: 1nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648262BDBM648262(US11884671, Example 39)
Affinity DataIC50: 1nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50599251BDBM50599251(CHEMBL5198414 | US11884671, Example 42)
Affinity DataIC50: 1.26nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648272BDBM648272(US11884671, Example 49)
Affinity DataIC50: 1.58nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50599244BDBM50599244(CHEMBL5182028 | US11884671, Example 41)
Affinity DataIC50: 2.51nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50599236BDBM50599236(CHEMBL5186637 | US11884671, Example 44)
Affinity DataIC50: 3.16nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648273BDBM648273(US11884671, Example 50)
Affinity DataIC50: 3.98nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 648269BDBM648269(US11884671, Example 46)
Affinity DataIC50: 7.94nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

Displayed 1 to 50 (of 364 total ) | Next | Last >>
Jump to: